[Transforming growth factor-beta as a therapeutic target].
Transforming growth factor-beta (TGF-beta) family members include TGF-beta, activins, and bone morphogenetic proteins (BMP). These proteins are structurally related cytokines secreted in diverse Metazoans. TGF-beta family members regulate cellular functions such as proliferation, apoptosis, differentiation, and migration, and play an important role in organism development. Deregulated TGF-beta family signaling participates in various human pathologies including autoimmune diseases, vascular disorders, fibrotic disease, and cancer. Ligand-induced activation of TGF-beta family receptors with intrinsic serine/threonine kinase activity, triggers phosphorylation of the intracellular effectors of TGF-beta signaling, the Smads proteins. Once these proteins are activated they translocate into the nucleus, where they induce transcription of target genes and regulate cellular processes and functions. Novel therapeutic strategies are currently being developed to correct alterations in pathologies that involve TGF-beta as the main mediator. The English version of this paper is available at: http://www.insp.mx/salud/index.html.
Instituto de Biología Molecular y Terapia Génica, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Jalisco, México.
Francisco Javier
FJ
Gálvez-Gastélum
Ana Soledad
AS
Sandoval-Rodríguez
Juan
J
Armendáriz-Borunda
D000818:Animals; D002986:Clinical Trials as Topic; D006801:Humans; D010766:Phosphorylation; D016212:Transforming Growth Factor beta / Q000627:therapeutic use*
D016212:Transforming Growth Factor beta